Bluejay Diagnostics, Inc. (BJDX)
NASDAQ: BJDX · Real-Time Price · USD
3.712
-0.089 (-2.33%)
Mar 31, 2025, 2:34 PM EDT - Market open
Bluejay Diagnostics Market Cap
Bluejay Diagnostics has a market cap or net worth of $2.00 million as of March 31, 2025. Its market cap has increased by 25.44% in one year.
Market Cap
2.00M
Enterprise Value
-3.51M
1-Year Change
25.44%
Ranking
Category
Stock Price
$3.71
Market Cap Chart
Since the IPO on November 10, 2021, Bluejay Diagnostics's market cap has decreased from $67.50M to $2.00M, a decrease of -97.04%. That is a compound annual growth rate of -64.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 2.05M | -21.77% |
| Dec 31, 2024 | 2.62M | 73.26% |
| Dec 29, 2023 | 1.51M | -80.26% |
| Dec 30, 2022 | 7.66M | -84.66% |
| Dec 31, 2021 | 49.91M | -26.06% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |